Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02478177 · ClinicalTrials.gov registry record
Addressing Real-world Anticoagulant Management Issues in Stroke
A clinical trial of Stroke and Intracerebral Hemorrhage, sponsored by Duke University.
- Completed
- Registry status
- 6,000
- Enrollment target
- 1
- Study location
NCT02478177: Completed study of Stroke and Intracerebral Hemorrhage, sponsored by Duke University.
NCT02478177 is a study of Stroke and Intracerebral Hemorrhage that has completed, run by Duke University. The registered enrollment target is 6,000 participants, below the 12,003-participant average among 454 other Stroke trials with a reported enrollment target (50% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02478177, a study of Stroke and Intracerebral Hemorrhage, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 6,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) registry is designed to provide important and timely insight into the management of acute stroke patients who are on novel oral anticoagulants in community practice.
Primary Outcome
Prevalence of novel oral anticoagulants will be abstracted from the medical record
Conditions Studied
Study Locations (1)
North Carolina
- 300 West Morgan Street, Duke Clinical Research Institute - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,000 participants |
| Start Date | 2015-09 |
| Est. Completion | 2019-12 |
What the finished NCT02478177 record still lists
NCT02478177 is an observational study that tracks outcomes without assigning an intervention. Its 6,000 participants enrollment target places it among the larger protocols in the corpus, below the 12,003-participant average among 454 other Stroke trials with a reported enrollment target (50% lower).
The record links to 3 conditions, with Stroke appearing as the primary indexed condition, and to 0 interventions.
NCT02478177 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT02478177 about?
NCT02478177 is a clinical study titled "Addressing Real-world Anticoagulant Management Issues in Stroke". The Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) registry is designed to provide important and timely insight into the management of acute stroke patients who are on novel oral anticoagulants in community practice.
What is the current status of trial NCT02478177?
This trial is currently completed. The enrollment target is 6,000 participants. The study started on 2015-09. Estimated completion is 2019-12.
What conditions does trial NCT02478177 study?
This clinical trial studies the following conditions: Stroke, Intracerebral Hemorrhage, Cerebrovascular Stroke.
Who is sponsoring clinical trial NCT02478177?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02478177 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02478177's enrollment target sits among peer trials
6,000 12th of 454 higher than 443 of 454 other Stroke trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
The SLEEPR Study: SLEep Effects on Post-stroke Rehabilitation
RECRUITING
-
Tracking a Tactile Signal Along the Nervous System
RECRUITING · NA
-
Transcranial Direct Current Stimulation (tDCS) With Verb Network Strengthening Treatment (VNeST) in Chronic Aphasia
RECRUITING · NA
-
Genetic and Environmental Risk Factors for Hemorrhagic Stroke
RECRUITING
-
Strategy Training for Individuals With Unilateral Neglect
RECRUITING · NA
-
Weight Loss and ExeRcise
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00005095 · 6,000 participants
Specimen and Data Study for Ovarian Cancer Early Detection and Prevention
- NCT00280202 · 6,000 participants
Detection of Genetic Markers of Lung Cancer
- NCT03127631 · 6,000 participants · NA
A RAndomizeD Intervention for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
- NCT03539705 · 6,000 participants
Food Allergy Registry at a Single Site
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia